Effects of High-Fat Meal on the Pharmacokinetic and Pharmacodynamic Properties and Safety Profile of Aranidipine Enteric-Coated Capsule in Healthy Chinese Subjects
DU Hai-yan,YANG Yue-han,LI Jing,YANG Ke-xu,LIN Yang,WU Xue-si,JIE Bing-zhang,FANG Shan-juan,YAN Xiu-juan,JIA Xiao-xin,ZHOU Zi-jie,WU Wei,SUO Wei,ZHAO Gui-ping
2011-01-01
Abstract:OBJECTIVE To assess the effects of high-fat meal on the pharmacokinetic(PK) and pharmacodynamic(PD) properties and safety profile of aranidipine(AR) and its active metabolite,hydroxyl-aranidipine(AR-M1),in health Chinese subjects.METHODS One single-dose,open-label,randomized,crossover study of oral aranidipine enteric-coated capsule was conducted in healthy Chinese subjects.Twelve healthy nonsmoking subjects(6 males,6 females) aged from 18 to 45 years were orally administrated aranidipine enteric-coated capsule 10 mg in fasted state.After a washout period of 1 week,the subjects were orally administrated aranidipine enteric-coated capsule 10 mg after high-fat breakfast.Plasma samples were collected previous to the administration as well as at indicated time points after the administration.Concentrations of AR and AR-M1 in plasma were determined by HPLC-MS/MS.PK parameters(AUC0-t,AUC0-∞,ρmax,tmax,t1/2,Ke,CL/F,Vd/F,etc.) of AR and AR-M1 were calculated with DAS 2.1.1.Systolic and diastolic blood pressure(SBP and DBP) and heart rate(HR) were measured before and at indicated time points after the administration.Safety profile assessment was performed throughout the experiment.RESULTS There was significant increase in AUC0-t,AUC0-∞,and tmax for AR given after high-fat meal compared with those in fasted condition(P<0.05).For AR-M1,there was extremely significant increase in tmax(P<0.01) under high-fat meal condition and no significant difference in other parameters(P>0.05).There were no significant changes in BP and HR after the administration in a high-fat meal state compared with that in fasted state.Compared with baseline,there was significant decrease in DBP at 8 h after the administration in both fasted and high-fat meal state(P<0.05).CONCLUSION Oral administration of aranidipine enteric-coated capsule after high-fat meal results in slow absorption and significant increase in bioavailability of AR,as well as significant delay in the generation of AR-M1.There were no significant changes in BP and HR after the administration in either fasted or high-fat meal state.No serious AEs were observed during the experiment,showing the good safety profile of the agent.There is no need to adjust the dosage in clinic application,but light-food and administration in fasted state are recommended.